• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

25
3
3
3
1

COUNTRY

3
1

CATEGORIES

  • 52
  • 11
  • 7
  • 6
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

22
23
40
93

PUBLISHED

2
3
16
93

PRODUCT TYPE

86
3
3
1

Search "Millennium Biotechnologies Group, Inc." returned 93 results.

Inergetics, Inc. (Formerly Millennium Biotechnologies Group, Inc.)Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Project Synopsis: Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by...

June 2013
FROM

Lymphoma Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Lymphoma Therapeutics in US$ Million The report provides separate comprehensive analytics for US, Europe, and Rest of World Annual estimates and forecasts...

April 2010
FROM

Prostate Cancer - Pipeline Review, H2 2013

Prostate Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Prostate Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

August 2013
FROM

Endometrial Cancer - Pipeline Review, H1 2015

Endometrial Cancer - Pipeline Review, H1 2015 Summary This, ‘Endometrial Cancer - Pipeline Review, H1 2015’, provides an overview of the Endometrial Cancer’s therapeutic pipeline. This report provides...

May 2015
FROM

Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

The Pharma and Biotech M&A Trends 2009-2014 report provides comprehensive understanding and unprecedented access to the merger and acquisition agreements entered into by the worlds leading biopharma...

July 2014
FROM

Ovarian Cancer - Pipeline Review, H2 2013

Ovarian Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Ovarian Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

October 2013
FROM

Osteosarcoma Global Clinical Trials Review, H2, 2013

Osteosarcoma Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Osteosarcoma Global Clinical Trials Review, H2, 2013" provides data on the Osteosarcoma clinical trial scenario....

September 2013
FROM

Multiple Myeloma Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Multiple Myeloma Therapeutics in US$ Million The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World Annual estimates...

October 2011
FROM

Biopharmaceutical Contract Manufacturing Market, 2015 - 2025

Characterized by a rapidly expanding product pipeline and a capital intensive manufacturing business, the biopharmaceutical market is witnessing a growing trend towards contract manufacturing. In addition...

May 2015
FROM

Skin Cancer - Pipeline Review, H1 2013

Skin Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Skin Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

May 2013
FROM

Gynecological Cancer - Pipeline Review, H1 2013

Gynecological Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Gynecological Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

May 2013
FROM

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2014

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2014’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s...

February 2014
FROM

Ovarian Cancer - Pipeline Review, H2 2014

Ovarian Cancer - Pipeline Review, H2 2014 Summary This, ‘Ovarian Cancer - Pipeline Review, H2 2014’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Non-Small Cell Lung Cancer - Pipeline Review, H2 2013

Non-Small Cell Lung Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Non-Small Cell Lung Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

August 2013
FROM

2016 Healthcare Practice and Attorney Rate Report

The 2016 Healthcare Practice and Rate Report examines the hourly rates of Attorneys (partners, counsel, senior associates and associates) at the law firms most active in the healthcare sector. Rates...

July 2015
FROM

Ovarian Cancer - Pipeline Review, H1 2014

Ovarian Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2014’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report...

April 2014
FROM

Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024

Antibody drug conjugates (ADCs) are a new class of therapeutic agents, gaining increasing attention from both large and small pharmaceutical companies. Generally addressed as the marriage of an antibody...

August 2014
FROM

Therapeutic Monoclonal Antibodies Markets

Antibodies are proteins in the immune system that help the body defend against foreign invasion, particularly from pathogens and toxins. As such, a human-engineered therapeutic monoclonal antibody (mAb)...

June 2009
FROM

Hepatocellular Carcinoma - Pipeline Review, H2 2014

Hepatocellular Carcinoma - Pipeline Review, H2 2014 Summary This, ‘Hepatocellular Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Hepatocellular Carcinoma’s therapeutic pipeline. This...

November 2014
FROM

Breast Cancer - Pipeline Review, H2 2013

Breast Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Breast Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

October 2013
FROM
Loading Indicator

Our Clients

Glanbia Plc. Unilever N.V. Microsoft Corporation Duke University A.T. Kearney PepsiCo Inc. Boston Consulting Group